Loading company…
La Tronche, France developer of off-the-shelf cancer immunotherapies based on its proprietary PDCline dendritic cell technology.
Founded in 2014 by Laurent LEVY and based in La Tronche, France, PDC Line Pharma SAS develops off-the-shelf cancer immunotherapies using its proprietary PDCline plasmacytoid dendritic cell technology. Its pipeline includes PDCmel for melanoma, which completed a Phase Ib trial, PDC lung for non-small-cell lung cancer, and PDC Neo, which is in preclinical development. In January 2024 it received EUR 4.7 million in grant funding from Société Régionale d'Investissement de Wallonie and BioWin.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in